March 3, 2026Open Access

Establishment and validation of a prognostic model based on liquid-liquid phase separation-related genes in gastric cancer

Key Points

The study establishes a prognostic model centered on liquid-liquid phase separation-associated genes in gastric cancer.
Key evidence indicates the potential of genes like VCAN and APOD to serve as therapeutic targets.
Validation of the model was conducted through comprehensive analysis of identified genes in gastric cancer cases.
Significance lies in the possibility of using these genes to guide future therapeutic interventions, enhancing treatment outcomes.

Abstract

Our research establishes and validates an LLPS-associated risk model centered on the genes VCAN, APOD, MYB, SNCG, F5, and BRI3BP. These genes are poised to be considered as potential therapeutic targets in the treatment of GC.

Establishment and validation of a prognostic model based on liquid-liquid phase separation-related genes in gastric cancer

Key Points

Abstract

Cite This Study